166 related articles for article (PubMed ID: 11753905)
41. Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
Gaspari R; Cavaliere F; Sollazzi L; Perilli V; Melchionda I; Agnes S; Gasbarrini A; Avolio AW
Transplant Proc; 2009; 41(1):253-8. PubMed ID: 19249528
[TBL] [Abstract][Full Text] [Related]
42. Characterization of pro-apoptotic effect of liver failure plasma on primary human hepatocytes and its modulation by molecular adsorbent recirculation system therapy.
Saich R; Selden C; Rees M; Hodgson H
Artif Organs; 2007 Sep; 31(9):732-42. PubMed ID: 17725701
[TBL] [Abstract][Full Text] [Related]
43. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin.
Yang WS; Tan HK; Lui HF; Chow PK; Choong HL; Wong KS
Artif Organs; 2008 May; 32(5):411-6. PubMed ID: 18471171
[TBL] [Abstract][Full Text] [Related]
44. Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients.
Stefoni S; Colì L; Bolondi L; Donati G; Ruggeri G; Feliciangeli G; Piscaglia F; Silvagni E; Sirri M; Donati G; Baraldi O; Soverini ML; Cianciolo G; Boni P; Patrono D; Ramazzotti E; Motta R; Roda A; Simoni P; Magliulo M; Borgnino LC; Ricci D; Mezzopane D; Cappuccilli ML
Int J Artif Organs; 2006 Feb; 29(2):207-18. PubMed ID: 16552668
[TBL] [Abstract][Full Text] [Related]
45. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis.
Vaid A; Chweich H; Balk EM; Jaber BL
ASAIO J; 2012; 58(1):51-9. PubMed ID: 22210651
[TBL] [Abstract][Full Text] [Related]
46. Mars and Prometheus: our clinical experience in acute chronic liver failure.
Faenza S; Baraldi O; Bernardi M; Bolondi L; Coli L; Cucchetti A; Donati G; Gozzetti F; Lauro A; Mancini E; Pinna AD; Piscaglia F; Rasciti L; Ravaioli M; Ruggeri G; Santoro A; Stefoni S
Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140
[TBL] [Abstract][Full Text] [Related]
47. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system.
Khoo AL; Tham LS; Lim GK; Lee KH
Liver Transpl; 2003 Sep; 9(9):949-53. PubMed ID: 12942456
[TBL] [Abstract][Full Text] [Related]
48. Liver support by extracorporeal blood purification: a clinical observation.
Stange J; Mitzner SR; Klammt S; Freytag J; Peszynski P; Loock J; Hickstein H; Korten G; Schmidt R; Hentschel J; Schulz M; Löhr M; Liebe S; Schareck W; Hopt UT
Liver Transpl; 2000 Sep; 6(5):603-13. PubMed ID: 10980060
[TBL] [Abstract][Full Text] [Related]
49. Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.
Evenepoel P; Laleman W; Wilmer A; Claes K; Maes B; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
Blood Purif; 2005; 23(5):349-58. PubMed ID: 16020951
[TBL] [Abstract][Full Text] [Related]
50. Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.
Klouche K; Cavadore P; Portales P; Clot J; Canaud B; Béraud JJ
J Nephrol; 2002; 15(2):150-7. PubMed ID: 12018631
[TBL] [Abstract][Full Text] [Related]
51. Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis.
Donati G; Piscaglia F; Colì L; Silvagni E; Righini R; Donati G; Pini P; Stefoni S; Bolondi L
Aliment Pharmacol Ther; 2007 Sep; 26(5):717-26. PubMed ID: 17697205
[TBL] [Abstract][Full Text] [Related]
52. Pediatric acute liver failure with molecular adsorbent recirculating system treatment.
Novelli G; Rossi M; Morabito V; Pugliese F; Ruberto F; Perrella SM; Novelli S; Spoletini G; Ferretti G; Mennini G; Berloco PB
Transplant Proc; 2008; 40(6):1921-4. PubMed ID: 18675090
[TBL] [Abstract][Full Text] [Related]
53. Review article: clinical experience with Prometheus.
Rifai K; Manns MP
Ther Apher Dial; 2006 Apr; 10(2):132-7. PubMed ID: 16684214
[TBL] [Abstract][Full Text] [Related]
54. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
[TBL] [Abstract][Full Text] [Related]
55. Prometheus system: a technological support in liver failure.
Santoro A; Faenza S; Mancini E; Ferramosca E; Grammatico F; Zucchelli A; Facchini MG; Pinna AD
Transplant Proc; 2006 May; 38(4):1078-82. PubMed ID: 16757270
[TBL] [Abstract][Full Text] [Related]
56. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
Krisper P; Stauber RE
Nat Clin Pract Nephrol; 2007 May; 3(5):267-76. PubMed ID: 17457360
[TBL] [Abstract][Full Text] [Related]
57. Experience of Mars therapy with and without transplantation in 101 patients with liver insufficiency.
Koivusalo AM; Vakkuri A; Höckerstedt K; Isoniemi H
Transplant Proc; 2005 Oct; 37(8):3315-7. PubMed ID: 16298584
[TBL] [Abstract][Full Text] [Related]
58. Emerging indications for albumin dialysis.
Sen S; Williams R; Jalan R
Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
[TBL] [Abstract][Full Text] [Related]
59. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD).
Sauer IM; Goetz M; Steffen I; Walter G; Kehr DC; Schwartlander R; Hwang YJ; Pascher A; Gerlach JC; Neuhaus P
Hepatology; 2004 May; 39(5):1408-14. PubMed ID: 15122770
[TBL] [Abstract][Full Text] [Related]
60. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
